Ertapenem in Patients With Urosepsis
Condition(s):Patients With Urosepis and Received Ertapenem for TreatmentLast Updated:March 1, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Patients With Urosepis and Received Ertapenem for TreatmentLast Updated:March 1, 2019Unknown status
Condition(s):Benign Prostatic Hyperplasia (BPH) Requiring Surgical ResectionLast Updated:February 1, 2016Completed
Condition(s):End Stage Renal DiseaseLast Updated:October 17, 2018Completed
Condition(s):Staphylococcus Aureus Bacteremia; Staphylococcus Aureus Septicemia; Staphylococcal Sepsis; Staphylococcus Aureus EndocarditisLast Updated:March 9, 2022Unknown status
Condition(s):PK of Ertapenem in TB PatientsLast Updated:August 25, 2017Completed
Condition(s):Hidradenitis SuppurativaLast Updated:February 24, 2022Withdrawn
Condition(s):Burn PatientsLast Updated:November 4, 2012Completed
Condition(s):Acute Kidney FailureLast Updated:September 28, 2012Completed
Condition(s):EndometritisLast Updated:May 20, 2015Terminated
Condition(s):IgE-Mediated Hypersensitivity; AllergyLast Updated:January 5, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.